Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Equitable Acces and Adherence to Secondary Prevention Therapy With a Fixed-Dose Combination Drug
Brief Summary: The aim of the FOCUS project is to test the Fixed Dose Combination concept for cardiovascular prevention in populations of different socio-economic characteristics. At the same time, FOCUS aims to understand the factors determining inappropriate prescribing for secondary cardiovascular prevention and those for poor patients adherence to treatment. This will allow FOCUS to establish recommendations for a better use of medication in patients with ischemic heart disease. In addition, after a successful completion of FOCUS, secondary prevention medication will be available and affordable for a large number of patients in both developed as well as developing countries.

There are two Phases in this study:

Phase 1: Is a descriptive, non interventional study. Phase 2: Is an interventional, randomized trial with prospective economic evaluation.


Options:
A: Arm Label: 1, POLYCAP; Type: EXPERIMENTAL; Interventions: Drug: POLYCAP | Arm Label: 2 B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Thiazides | Arm Label: 3 C; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ramipril with Thiazide | Arm Label: 4 D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Thiazide plus atenolol | Arm Label: 5, E; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ramipril plus atenolol | Arm Label: 6, F; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ramipril plus atenolol plus thiazide | Arm Label: 7,G; Type: ACTIVE_COMPARATOR; Interventions: Drug: Thiazide + Ramipril+Atenolol+Aspirin | Arm Label: 8,H; Type: ACTIVE_COMPARATOR; Interventions: Drug: Simvastatin | Arm Label: 9,A; Type: ACTIVE_COMPARATOR; Interventions: Drug: aspirin | Intervention Type: DRUG; Name: Thiazides; Assigned to Arm(s): 2 B | Intervention Type: DRUG; Name: Ramipril with Thiazide; Assigned to Arm(s): 3 C | Intervention Type: DRUG; Name: Thiazide plus atenolol; Assigned to Arm(s): 4 D | Intervention Type: DRUG; Name: Ramipril plus atenolol; Assigned to Arm(s): 5, E | Intervention Type: DRUG; Name: Ramipril plus atenolol plus thiazide; Assigned to Arm(s): 6, F | Intervention Type: DRUG; Name: POLYCAP; Assigned to Arm(s): 1, POLYCAP | Intervention Type: DRUG; Name: Thiazide + Ramipril+Atenolol+Aspirin; Assigned to Arm(s): 7,G | Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): 8,H | Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): 9,A
B: Arm Label: FDC Fixed Dose Combination; Type: EXPERIMENTAL; Interventions: Drug: FDC | Arm Label: Conventional treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Separately drugs, simvastatin, aspirin and ramipril | Intervention Type: DRUG; Name: FDC; Assigned to Arm(s): FDC Fixed Dose Combination | Intervention Type: DRUG; Name: Separately drugs, simvastatin, aspirin and ramipril; Assigned to Arm(s): Conventional treatment
C: Arm Label: Polypill in the morning; Type: EXPERIMENTAL; Interventions: Drug: Cardiovascular Agents | Arm Label: Polypill in the evening; Type: EXPERIMENTAL; Interventions: Drug: Cardiovascular Agents | Arm Label: Individual agents of the polypill); Type: ACTIVE_COMPARATOR; Interventions: Drug: Cardiovascular Agents | Intervention Type: DRUG; Name: Cardiovascular Agents; Assigned to Arm(s): Individual agents of the polypill), Polypill in the evening, Polypill in the morning
D: Arm Label: The Red Heart Pill 2b (Polypill) (A); Type: EXPERIMENTAL; Interventions: Drug: Red Heart Pill 2b (Polypill) | Arm Label: Standard Practice Group (B); Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Practice | Intervention Type: DRUG; Name: Red Heart Pill 2b (Polypill); Assigned to Arm(s): The Red Heart Pill 2b (Polypill) (A) | Intervention Type: OTHER; Name: Standard Practice; Assigned to Arm(s): Standard Practice Group (B)

Answer: B